|
Market Closed -
Euronext Paris
16:55:00 17/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.7110 EUR | -0.56% |
|
-5.83% | -25.94% |
| 11-09 | Transgene Provides Update on Myvac-Based Individualized Assets Tg4050 and Tg4070 | CI |
| 11-09 | Transgene confirms financial visibility through 2028 |
Company Valuation: Transgene
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 247.8 | 164.8 | 137.8 | 89.75 | 262.9 | 194.7 | - | - |
| Change | - | -33.52% | -16.38% | -34.86% | 192.89% | -25.92% | - | - |
| Enterprise Value (EV) 1 | 214.9 | 151.4 | 139.4 | 83.48 | 153.1 | 125.5 | 187 | 213.3 |
| Change | - | -29.53% | -7.95% | -40.12% | 83.37% | -17.99% | 48.99% | 14.06% |
| P/E | -12.1x | -5.02x | -6.23x | -2.34x | -3.69x | -5.08x | -3.23x | -7.9x |
| PBR | 3.69x | 4.38x | 8.82x | 5.92x | 1.14x | 2.37x | 8.89x | -71.1x |
| PEG | - | -0.1x | 0.2x | -0.1x | 0.4x | 0.1x | -0.1x | 0.1x |
| Capitalization / Revenue | 14.2x | 15.9x | 17.4x | 14.1x | 36.5x | 27x | 27x | 3.42x |
| EV / Revenue | 12.3x | 14.6x | 17.6x | 13.1x | 21.2x | 17.4x | 26x | 3.74x |
| EV / EBITDA | -10.2x | -5.37x | -4.9x | -2.43x | -4.54x | -2.88x | -2.67x | -9.04x |
| EV / EBIT | -9.14x | -5.06x | -4.64x | -2.34x | -4.37x | -2.83x | -2.64x | -7.28x |
| EV / FCF | -6.59x | -6.94x | -1,408x | -3.12x | -1.07x | -3.16x | -3.1x | -8.5x |
| FCF Yield | -15.2% | -14.4% | -0.07% | -32% | -93.4% | -31.6% | -32.3% | -11.8% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.21 | -0.33 | -0.22 | -0.29 | -0.26 | -0.14 | -0.22 | -0.09 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 17.41 | 10.34 | 7.9 | 6.353 | 7.21 | 7.2 | 7.2 | 57 |
| EBITDA 1 | -21 | -28.22 | -28.48 | -34.38 | -33.73 | -43.6 | -70.1 | -23.6 |
| EBIT 1 | -23.52 | -29.9 | -30.05 | -35.66 | -35.06 | -44.3 | -70.8 | -29.3 |
| Net income 1 | -19.54 | -32.8 | -22.33 | -33.97 | -37.52 | -38.2 | -61.6 | -25.3 |
| Net Debt 1 | -32.93 | -13.31 | 1.629 | -6.274 | -109.8 | -69.2 | -7.7 | 18.6 |
| Reference price 2 | 2.5400 | 1.6580 | 1.3700 | 0.6800 | 0.9600 | 0.7110 | 0.7110 | 0.7110 |
| Nbr of stocks (in thousands) | 97,576 | 99,370 | 100,566 | 131,990 | 273,827 | 273,882 | - | - |
| Announcement Date | 16/03/22 | 16/03/23 | 27/03/24 | 27/03/25 | 24/03/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -5.11x | 17.59x | -2.9x | - | 216M | ||
| 17.13x | 6.55x | 12.55x | 1.74% | 65.56B | ||
| 32.67x | 8.73x | 28.87x | 0.07% | 60.41B | ||
| 38.83x | 6.91x | 20.67x | 0.84% | 55.76B | ||
| 44.13x | 6.17x | 29.36x | -.--% | 46.98B | ||
| 34.55x | 3.29x | 14.19x | -.--% | 43.63B | ||
| 36.23x | 8.96x | 23.37x | 0.36% | 36.7B | ||
| -19.98x | 53.61x | -21.71x | -.--% | 36.09B | ||
| 41.91x | 8.08x | 27.1x | -.--% | 32.9B | ||
| -74.98x | 14.21x | -76.38x | -.--% | 26.96B | ||
| Average | 14.54x | 13.41x | 5.51x | 0.33% | 41B | |
| Weighted average by Cap. | 21.74x | 11.58x | 11.41x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- TNG Stock
- Valuation Transgene
Select your edition
All financial news and data tailored to specific country editions
















